Selbyville, Delaware , Nov. 24, 2020 (GLOBE NEWSWIRE) -- According to industry experts, global cancer immunotherapy market size is projected to reach USD 117.82 billion by the year 2026. Spike in the number of cases of cancer and associated deaths is fueling the industry growth. WHO claims that in 2015, around 17.6 million cancer cases were registered, which increased to 18.1 million in 2018 with approximately 9.6 million mortalities. In 2019, cancer became the second leading cause of death globally. Also, it is estimated that every 1 in 6 deaths is due to cancer each year across the globe.
In-depth segmentation studies including type, application scope, and end user-scope are furnished in the report. Further, the research literature fragments the industry sphere into North America, South America, Asia Pacific, Europe, and MEA. These regions are sub-divided to offer an exhaustive overview of the key economies and identify the top investments regions. Proceeding further, a comprehensive summary of foremost players operating in this industry is offered to comprehend their position and footmark in the evolving marketplace.
Further, WHO states that nearly one-third of the cancer deaths are due to behavior and dietary risks including low fruits & vegetables consumption, sedentary lifestyle, high body mass index, and increased alcohol consumption. Besides, tobacco is among the prominent causes for the prevalence of cancer and mortalities, accounting for about 22% of the global population. These factors coupled with increasing smoking population and unprecedented increase in urban air pollution are elevating the risk of cancer, thereby accelerating the overall cancer immunotherapy industry growth.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2963749/
Besides, increasing approvals for new immunotherapy drugs for treatment of various cancer types such as prostate cancer, melanoma, blood cancer, colorectal cancer, lung cancer, breast cancer, and others is adding considerable momentum to industry expansion. Moreover, benefits like long-lived effects, enhanced survival rates, and exceptional specificity in comparison to conventional therapies has bolstered the demand for cancer immunotherapy.
Outlining market segmentation:
Worldwide cancer immunotherapy industry, as per type, is classified into check point inhibitors & immunomodulators, cancer vaccines, and monoclonal antibodies. Speaking of application scope, the market is segmented into head & neck cancer, prostate cancer, melanoma, colorectal cancer, breast cancer, and lung cancer. While the end-user spectrum is comprised of clinics, hospitals, and others.
Regional outlook:
Asia Pacific cancer immunotherapy market is expected to grow significantly during the forecast period due to presence of a large patient base in several Asian nations. Cancer is the leading cause of morality in China, with 4 million new cases registered each year. Whereas, South Korea records over 200,000 new cases annually. Japan’s National Cancer Institute recorded 1,49,000 cases in 2017. India had alarming 1,85,000 incidences of colorectal cancer in 2017. Apart from this, increasing healthcare expenditure in developing economy is accelerating the regional market growth.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Global Cancer Immunotherapy Market Type Sub-Segments (Revenue, USD Billion, 2015-2026)
- Cancer Vaccines
- Monoclonal Antibodies
- Check Point Inhibitors & Immunomodulators
Global Cancer Immunotherapy Market Application Scope (Revenue, USD Billion, 2015-2026)
- Breast Cancer
- Lung Cancer
- Melanoma
- Colorectal Cancer
- Prostate Cancer
- Head and Neck
Global Cancer Immunotherapy Market End-User Spectrum (Revenue, USD Billion, 2015-2026)
- Clinics
- Hospitals
- Others
Global Cancer Immunotherapy Market Regional Bifurcation (Revenue, USD Billion, 2015-2026)
North America
- United States
- Canada
Latin America
- Brazil
- Mexico
- Colombia
Asia Pacific
- China
- Japan
- South Korea
- India
Europe
- United Kingdom
- Germany
- Italy
- France
- Spain
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
Global Cancer Immunotherapy Market Competitive Backdrop (Revenue, USD Billion, 2015-2026)
- Novartis International AG
- Merck and Co. Inc.
- F. Hoffmann-La Roche AG
- Eli Lily and Co.
- Bristol-Myers Squibb
- AstraZeneca plc
- Astellas Pharma Inc.
- Amgen Inc.
- OSE Immunotherapeutics
- Bayer AG
Table of Content:
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.4. Secondary data sources
1.5. Key take-aways
1.6. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Cancer Immunotherapy Market Insights
3.1. Cancer Immunotherapy- Industry snapshot
3.2. Cancer Immunotherapy market dynamics
3.2.1. Cancer Immunotherapy- Market Forces
3.2.1.1. Cancer Immunotherapy Market driver analysis
3.2.1.2. Cancer Immunotherapy Market restraint/challenges analysis
3.2.1.3. Cancer Immunotherapy Market opportunity analysis
3.3. Industry analysis - Porter's five force
3.3.1. Bargaining power of supplier
3.3.2. Bargaining power of buyer
3.3.3. Threat of substitute
3.3.4. Threat of new entrant
3.3.5. Degree of competition
3.4. Cancer Immunotherapy market PEST analysis
3.5. Value Chain Analysis
4. Cancer Immunotherapy Market Size and Forecast by Type
4.1. Global Cancer Immunotherapy market share by type, 2019 & 2026
4.2. Monoclonal Antibodies
4.3. Cancer Vaccines
4.4. Check Point Inhibitors & Immunomodulators
5. Cancer Immunotherapy Market Size and Forecast by Application
5.1. Global Cancer Immunotherapy market share by application, 2019 & 2026
5.2. Lung Cancer
5.3. Breast Cancer
5.4. Colorectal Cancer
5.5. Melanoma
5.6. Prostate Cancer
5.7. Head and Neck
6. Cancer Immunotherapy Market Size and Forecast by End-user
6.1. Global Cancer Immunotherapy market share by end-user, 2019 & 2026
6.2. Hospitals
6.2.1. Global Cancer Immunotherapy market for Hospitals as end-user, estimates and forecasts, 2015 - 2026 (USD Billion)
6.2.2. Global Cancer Immunotherapy market for Hospitals as end-user, estimates and forecasts, by region, 2015 - 2026 (USD Billion)
6.3. Clinics
6.3.1. Global Cancer Immunotherapy market for Clinics as end-user, estimates and forecasts, 2015 - 2026 (USD Billion)
6.3.2. Global Cancer Immunotherapy market for Clinics as end-user, estimates and forecasts, by region, 2015 - 2026 (USD Billion)
6.4. Others
6.4.1. Global Cancer Immunotherapy market for Other end-user, estimates and forecasts, 2015 - 2026 (USD Billion)
6.4.2. Global Cancer Immunotherapy market for Other end-user, estimates and forecasts, by region, 2015 - 2026 (USD Billion)
7. Cancer Immunotherapy Market Size and Forecast by Region
Related Report:
Cancer Diagnostics Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
Cancer Diagnostics Market size is expected to grow at 8.5% CAGR between 2020 and 2026, as per new research report. Growing adoption of unhealthy diet including excessive fat and sugar content coupled with reduction in physical exercise has escalated number of people suffering from diabetes and cancer. According to the WHO, cancer is the second leading cause of death worldwide, accounting over 9.6 million deaths in 2018. Such number has led to increase in adoption of cancer diagnostics. Latin America is anticipated to emerge as a lucrative growth ground for cancer diagnostics market, driven by the robust prevalence of cancer in the region. Latin America market is anticipated to cross USD 7.3 billion by 2026, with regional governments providing ample funding for research activities to detect new techniques of diagnosis. Also, the healthcare infrastructure in the region has been developed to a great extent, making it a viable avenue for cancer diagnostics business.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.